Hou J, Berg T, Vogel A, Piratvisuth T, Trojan J, De Toni E
JHEP Rep. 2025; 7(2):101263.
PMID: 39897614
PMC: 11782856.
DOI: 10.1016/j.jhepr.2024.101263.
Ma S, Yi L, Bian Y, Lv B, Zhang C, Li C
Cancer Chemother Pharmacol. 2024; 95(1):5.
PMID: 39673613
DOI: 10.1007/s00280-024-04725-w.
Raghav A, Jeong G
Int J Mol Sci. 2024; 25(17).
PMID: 39273237
PMC: 11395253.
DOI: 10.3390/ijms25179286.
Patel A, Dossaji Z, Gupta K, Roma K, Chandler T, Minacapelli C
Gastro Hep Adv. 2024; 3(2):139-150.
PMID: 39129942
PMC: 11307719.
DOI: 10.1016/j.gastha.2023.10.008.
Cao M, Xia C, Cao M, Yang F, Yan X, He S
Cancer Biol Med. 2024; 21(8).
PMID: 39015006
PMC: 11359490.
DOI: 10.20892/j.issn.2095-3941.2024.0149.
Real-World Data on the Diagnosis, Treatment, and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT Study.
Sim Y, Chong M, Gandhi M, Pokharkar Y, Zhu Y, Shi L
Liver Cancer. 2024; 13(3):298-313.
PMID: 38756144
PMC: 11095624.
DOI: 10.1159/000534513.
Applying ONCO-RADS to whole-body MRI cancer screening in a retrospective cohort of asymptomatic individuals.
Hu Y, Wu C, Lin D, Lin P, Lee H, Lin L
Cancer Imaging. 2024; 24(1):22.
PMID: 38326850
PMC: 10848416.
DOI: 10.1186/s40644-024-00665-z.
Alcohol-induced liver injury in signalling pathways and curcumin's therapeutic potential.
Subramaniyan V, Lubau N, Mukerjee N, Kumarasamy V
Toxicol Rep. 2023; 11:355-367.
PMID: 37868808
PMC: 10585641.
DOI: 10.1016/j.toxrep.2023.10.005.
Protein phosphatase 2A-B55β mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling.
Qian B, Che L, Du Z, Guo N, Wu X, Yang L
Theranostics. 2023; 13(12):4288-4302.
PMID: 37554285
PMC: 10405852.
DOI: 10.7150/thno.82132.
Molecular Design, Spectroscopic, DFT, Pharmacological, and Molecular Docking Studies of Novel Ruthenium(III)-Schiff Base Complex: An Inhibitor of Progression in HepG2 Cells.
Noureldeen A, Aziz S, Shouman S, Mohamed M, Attia Y, Ramadan R
Int J Environ Res Public Health. 2022; 19(20).
PMID: 36294202
PMC: 9603487.
DOI: 10.3390/ijerph192013624.
Hepatocellular Carcinoma Recurrence and Mortality Rate Post Liver Transplantation: Meta-Analysis and Systematic Review of Real-World Evidence.
Bzeizi K, Abdullah M, Vidyasagar K, Alqahthani S, Broering D
Cancers (Basel). 2022; 14(20).
PMID: 36291898
PMC: 9599880.
DOI: 10.3390/cancers14205114.
Construction and validation of a prognostic marker and risk model for HCC ultrasound therapy combined with WGCNA identification.
Bi Y, Jing Y, Guo L
Front Genet. 2022; 13:1017551.
PMID: 36263426
PMC: 9573990.
DOI: 10.3389/fgene.2022.1017551.
Testis-specific protein Y-encoded 1 regulates androgen receptor expression through the MAPK/ERK pathway in male hepatocellular carcinoma.
Lu Z, Yang D, Qin S, Mo C, Zhang L, Ou Y
Saudi Med J. 2022; 43(10):1087-1095.
PMID: 36261201
PMC: 9994500.
DOI: 10.15537/smj.2022.43.10.20220455.
Changes in the Epidemiology of Hepatocellular Carcinoma in Asia.
Liu Y, Liu L
Cancers (Basel). 2022; 14(18).
PMID: 36139633
PMC: 9496757.
DOI: 10.3390/cancers14184473.
Inhibition of anti-inflammatory pathway through suppressors of cytokine signalling (Socs2/Socs3) in the initiation of hepatocellular carcinoma.
Ashfaq I, Sheikh N, Fatima N, Tayyeb A
Saudi J Biol Sci. 2022; 29(8):103348.
PMID: 35800143
PMC: 9253924.
DOI: 10.1016/j.sjbs.2022.103348.
The Combination of Age, International Standardized Ratio, Albumin and γ-Glutamyl Transpeptidase (AIAG), Tumor Size and Alpha Fetoprotein (AFP) Stage as the Prognostic Model for Hepatitis B-Related Hepatocellular Carcinoma.
Liu S, Xu Z, Fang Z, Zhang D, Qin Z, Fan L
Int J Gen Med. 2021; 14:4291-4301.
PMID: 34408472
PMC: 8364385.
DOI: 10.2147/IJGM.S323293.
Updates on the Diagnosis and Management of Hepatocellular Carcinoma.
Raees A, Kamran M, Ozkan H, Jafri W
Euroasian J Hepatogastroenterol. 2021; 11(1):32-40.
PMID: 34316462
PMC: 8286363.
DOI: 10.5005/jp-journals-10018-1335.
Hepatitis B-related hepatocellular carcinoma: surveillance strategy directed by immune-epidemiology.
Anugwom C, Allaire M, Akbar S, Sultan A, Bollipo S, Mattos A
Hepatoma Res. 2021; 7.
PMID: 33884303
PMC: 8057710.
DOI: 10.20517/2394-5079.2021.06.
High Expression of LINC01268 is Positively Associated with Hepatocellular Carcinoma Progression via Regulating MAP3K7.
Jin X, Fu W, Li D, Wang N, Chen J, Zeng Z
Onco Targets Ther. 2021; 14:1753-1769.
PMID: 33727826
PMC: 7954037.
DOI: 10.2147/OTT.S295814.
Low molecular weight fucoidan inhibits hepatocarcinogenesis and nonalcoholic fatty liver disease in zebrafish via ASGR/STAT3/HNF4A signaling.
Wu S, Yang W, Cheng C, Lin K, Sampurna B, Chan S
Clin Transl Med. 2020; 10(8):e252.
PMID: 33377648
PMC: 7752165.
DOI: 10.1002/ctm2.252.